AI Drug Discovery & Development Summit

Meet Myllia at the conference that places AI at the forefront of drug discovery and development. Neil Matharoo, VP commercial – US, is looking forward to connecting with the AI drug discovery community and showcase how our CROP-Seq/Perturb-Seq datasets can be used to train AI models and foster drug target discovery.